Dr. Desai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Ave
KS 218
Boston, MA 02215Phone+1 617-667-2100
Education & Training
- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2010 - 2013
- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2006 - 2009
- Baylor College of MedicineClass of 2006
- University of California, Los AngelesMS, Biomedical Engineering with focus in tissue engineering, 2000 - 2002
- Stanford UniversityBS, Biological Sciences, 1995 - 1999
Certifications & Licensure
- MA State Medical License 2009 - 2026
- NY State Medical License 2010 - 2014
- IL State Medical License 2007 - 2011
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- David Barnum Research Award for best grand rounds research presentation McGaw Medical Center of Northwestern University (ENH)
- 1st Place Research competition Association of American Physicians of Indian Origin National Conference
- Stuart Carl Harvey Award for Excellence in Gross Anatomy Baylor College of Medicine
- Join now to see all
Publications & Presentations
PubMed
- 195 citationsNeoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma: A Phase 2 Open-Label Randomized Clinical Trial.Jonathan D. Schoenfeld, Glenn J. Hanna, Vickie Y. Jo, Bhupendra Rawal, Yu-Hui Chen
JAMA Oncology. 2020-10-01 - 1404 citationsCTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition.Elizabeth I. Buchbinder, Anupam M. Desai
American Journal of Clinical Oncology. 2016-02-01 - 56 citationsNeoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck.Glenn J. Hanna, Anne O'Neill, Kee-Young Shin, Kristine S. Wong, Vickie Y. Jo
Clinical Cancer Research. 2021-10-19
Journal Articles
- Continued erlotinib maintenance and salvage radiation for solitary areas of disease progression: a useful strategy in selected non-small cell lung cancers?Marquez-Medina D, Chachoua A, Martin-Marco A, Desai AM, Garcia-Reglero V, Salud-Salvia A, Muggia F, Clin Transl Oncol., 11/1/2013
- “Pemphigus vulgaris in pregnancy”Desai AM, George S, Hsu S, Cortlandt Forum, 7/1/2007
- “Etanercept therapy for silicone granulomas”Desai AM, Browning J, Rosen T, J Drugs Dermatol, 10/1/2006
- Join now to see all
Press Mentions
- BIDMC’s Research & Health News Digest – April 2019 EditionApril 26th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: